Financial Advocates Investment Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,209
Closed -$281K 804
2022
Q3
$281K Sell
5,209
-212
-4% -$10.9K 0.02% 568
2022
Q2
$219K Sell
5,421
-348
-6% -$17.2K 0.02% 603
2022
Q1
$382K Buy
5,769
+225
+4% +$15.4K 0.03% 511
2021
Q4
$555K Buy
5,544
+175
+3% +$18.1K 0.04% 458
2021
Q3
$671K Sell
5,369
-20
-0.4% -$2.38K 0.05% 404
2021
Q2
$669K Hold
5,389
0.04% 416
2021
Q1
$823K Sell
5,389
-335
-6% -$50.6K 0.06% 371
2020
Q4
$738K Sell
5,724
-225
-4% -$25.9K 0.05% 363
2020
Q3
$665K Buy
5,949
+94
+2% +$8.6K 0.06% 320
2020
Q2
$475K Buy
5,855
+40
+0.7% +$3.22K 0.05% 369
2020
Q1
$405K Sell
5,815
-25
-0.4% -$1.92K 0.06% 311
2019
Q4
$456K Buy
5,840
+570
+11% +$41.1K 0.05% 329
2019
Q3
$336K Buy
5,270
+210
+4% +$18.5K 0.04% 364
2019
Q2
$437K Buy
5,060
+2,275
+82% +$174K 0.05% 313
2019
Q1
$214K Buy
+2,785
New +$154K 0.03% 425

Other funds holding GH

Financial Advocates Investment Management's GH Position: Q4 2022 in Review

Financial Advocates Investment Management sold out of Guardant Health (GH) in Q4 2022, closing a stake of 5,209 shares — an estimated $281K sold.

Financial Advocates Investment Management first reported a position in GH in Q1 2019 and held it in 15 quarters. The position peaked at $823K in Q1 2021. 292 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • Financial Advocates Investment Management reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • Financial Advocates Investment Management sold 5,209 Guardant Health shares in Q4 2022, an estimated $281K.
  • Financial Advocates Investment Management first reported a position in Guardant Health in Q1 2019 and held it in 15 quarters.
  • Financial Advocates Investment Management's Guardant Health position peaked at $823K in Q1 2021.
  • 292 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Financial Advocates Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.